Back
Viridian Therapeutics Stock Price Chart
7 Stocks to Buy and Hold Forever
The result is a select group of high-quality blue-chip stocks.
Buy
63
VRDN
Viridian Therapeutics
Last Price:
$15.89
Seasonality Move:
-3.6%
7 Day Trial
ALL ACCESS PASS
$
7
Sleep well at night with 7 stellar stocks to buy and hold forever
Get the complete list FREE for a limited time.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRDN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Viridian Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.12 | Buy |
| 20-day SMA: | 14.26 | Buy |
| 50-day SMA: | 13.37 | Buy |
| 200-day SMA: | 17.75 | Sell |
| 8-day EMA: | 15.25 | Buy |
| 20-day EMA: | 14.49 | Buy |
| 50-day EMA: | 14.18 | Buy |
| 200-day EMA: | 16.16 | Sell |
Viridian Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.63 | Buy |
| Relative Strength Index (14 RSI): | 67.56 | Buy |
| Chaikin Money Flow: | 614246 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.91 - 14.97) | Buy |
| Bollinger Bands (100): | (12.76 - 17.18) | Buy |
Viridian Therapeutics Technical Analysis
| Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Viridian Therapeutics Stock
Is Viridian Therapeutics Stock a Buy?
-
Viridian Therapeutics share price is 15.88 while VRDN 8-day simple moving average is 15.12, which is a Buy signal.
-
The stock price of VRDN is 15.88 while Viridian Therapeutics 20-day SMA is 14.26, which makes it a Buy.
-
Viridian Therapeutics 50-day simple moving average is 13.37 while VRDN share price is 15.88, making it a Buy technically.
-
VRDN stock price is 15.88 and Viridian Therapeutics 200-day simple moving average is 17.75, creating a Sell signal.
VRDN Technical Analysis vs Fundamental Analysis
Buy
63
Viridian Therapeutics (VRDN)
is a Buy
Is Viridian Therapeutics a Buy or a Sell?
-
Viridian Therapeutics stock is rated a BuyThe current Viridian Therapeutics [VRDN] share price is $15.88. The Score for VRDN is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Viridian Therapeutics Stock Info
Market Cap:
1.3B
Price in USD:
15.88
Share Volume:
708.7K
Viridian Therapeutics 52-Week Range
52-Week High:
27.20
52-Week Low:
9.90
Buy
63
Viridian Therapeutics (VRDN)
is a Buy
Viridian Therapeutics Share Price Forecast
-
What is the Viridian Therapeutics stock price today?The Viridian Therapeutics stock price is 15.88 USD today.
-
Will VRDN stock go up or go down?Viridian Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Viridian Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viridian Therapeutics is not overvalued.
Is Viridian Therapeutics Stock a Buy?
-
Viridian Therapeutics share price is 15.88 while VRDN 8-day exponential moving average is 15.25, which is a Buy signal.
-
The stock price of VRDN is 15.88 while Viridian Therapeutics 20-day EMA is 14.49, which makes it a Buy.
-
Viridian Therapeutics 50-day exponential moving average is 14.18 while VRDN share price is 15.88, making it a Buy technically.
-
VRDN stock price is 15.88 and Viridian Therapeutics 200-day simple moving average is 16.16, creating a Sell signal.
Fundamental Analysis of Viridian Therapeutics
Is Viridian Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.02 per share, and an increase next year of $0.31 per share.
Technical Analysis of Viridian Therapeutics
Should I short Viridian Therapeutics stock?
-
VRDN Moving Average Covergence Divergence (MACD) indicator is 0.63, suggesting Viridian Therapeutics is a Buy
-
Viridian Therapeutics Relative Strength Index (RSI) is 67.56, which suggest Viridian Therapeutics is overbought
-
The Bollinger Bands (25) for Viridian Therapeutics is (12.91 - 14.97), which suggest Viridian Therapeutics is a Buy
-
The Bollinger Bands (100) for Viridian Therapeutics is (12.76 - 17.18), which suggest Viridian Therapeutics is a Buy
* Viridian Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.